Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Japanese Children with Polyarticular JRA
NCT00690573Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2008
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in polyarticular juvenile idiopathic arthritis, sponsored by Abbott Laboratories. Started May 2008; status: completed.
02
Drugs
03
Conditions
polyarticular juvenile idiopathic arthritis
Beyond the preview
Go deeper on NCT00690573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690573.